OR
Oruka Therapeutics, Inc.
ORKA · NASDAQ
$92.20 -3.67% (-$3.51)
1M -14.85%
Market Cap $5.79B
P/E Ratio -
Div. Yield -
ROE 20.76%
Piotroski F-Score Weak
2/9Valuation
35 /100
Fair P/B 5.19x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 13.88%
Asset turnover 0.00x
ROE 20.76%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 38.51x
Int. coverage N/A
Stability
50 /100
Moderate Beta -0.39x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ORKA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lawrence Otto Klein
Employees
68
Headquarters
Menlo Park
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report